Fetal nicotine exposure harms breathing in infants

Fetal nicotine exposure harms breathing in infants
Whole muscle electromyographic activity in control and nicotine-exposed rats. Credit: Wollman et al., eNeuro 2019

Exposure to nicotine during development inhibits the function of neurons controlling the tongue, according to research in newborn rats recently published in eNeuro. This impairment may be a factor in sudden infant death syndrome in humans.

The hypoglossal nerve activates the muscles of the tongue. Wollman et al. exposed rats to nicotine in the womb and during the first few days of life. The team then measured the electrical activity of hypoglossal neurons during normal breathing and when breathing is stressed.

Normally, when breathing is obstructed, such as a blocking an animal's nostrils, a flood of excitatory neurotransmitters activate the hypoglossal neurons to move the tongue and open the airway. At rest, hypoglossal neurons in the rats exposed to nicotine behaved normally. However, during the breathing stressor test, the neurons from nicotine-exposed rats did not respond as robustly as those in the control rats, leading to difficulty breathing.

The researchers posit fetal and early life exposure in human babies could weaken their respiratory reflexes, increasing their susceptibility to in the face of a obstruction.

More information: Developmental Nicotine Exposure Alters Synaptic Input to Hypoglossal Motoneurons, and is Associated With Altered Function of Upper Airway Muscles, eNeuro, DOI: 10.1523/ENEURO.0299-19.2019

Citation: Fetal nicotine exposure harms breathing in infants (2019, November 11) retrieved 26 April 2024 from https://medicalxpress.com/news/2019-11-fetal-nicotine-exposure-infants.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

New way to study swallowing could one day lead to improved treatments for ALS

2 shares

Feedback to editors